We are live on ! Find out more
IMVT icon

Immunovant
IMVT

215 hedge funds and large institutions have $2.75B invested in Immunovant in 2026 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 93 increasing their positions, 40 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

619% more call options, than puts

Call options by funds: $61.3M | Put options by funds: $8.52M

133% more repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 40

92% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 24

10% more funds holding

Funds holding: 196 → 215 (+19)

1% less capital invested

Capital invested by funds: $2.76B → $2.75B (-$14.3M)

7.63% less ownership

Funds ownership: 61.96% → 54.34% (-7.6%)

13% less funds holding in top 10

Funds holding in top 10: 8 → 7 (-1)

Holders
215
Holders Change
+19
Holders Change %
+9.69%
% of All Funds
2.65%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.09%
New
46
Increased
93
Reduced
40
Closed
24
Calls
$61.3M
Puts
$8.52M
Net Calls
+$52.8M
Net Calls Change
+$26.3M

Top Buyers

1
TCM
TCG Crossover Management
California
+$72.4M
2
Jennison Associates
Jennison Associates
New York
+$64.6M
3
FCM
Farallon Capital Management
California
+$39.7M
4
State Street
State Street
Massachusetts
+$19.4M
5
Bank of America
Bank of America
North Carolina
+$15M

Top Sellers

1
AC
Armistice Capital
New York
-$56.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$50.8M
3
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$37.5M
4
Morgan Stanley
Morgan Stanley
New York
-$25.1M
5
SCM
Soleus Capital Management
Connecticut
-$22.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Asset Management
176
BNP Paribas Asset Management
France
$33.1K +$13.2K +508 +62%
GWM
177
Geneos Wealth Management
Colorado
$24.8K – – –
GI
178
GAMMA Investing
California
$17.5K +$4.97K +192 +38%
AF
179
Advisornet Financial
Minnesota
$16.7K +$2.56K +99 +17%
EFMH
180
E Fund Management (HK)
Hong Kong
$13.4K +$14K +541 New
SCM
181
Sterling Capital Management
North Carolina
$13.1K +$1.94K +75 +17%
AF
182
Allworth Financial
California
$12.5K +$673 +26 +5%
EWA
183
EverSource Wealth Advisors
Alabama
$11.9K +$4.97K +192 +67%
US Bancorp
184
US Bancorp
Minnesota
$8.84K +$1.45K +56 +19%
Fifth Third Bancorp
185
Fifth Third Bancorp
Ohio
$7.92K +$8.26K +319 New
RTL
186
Red Tortoise LLC
Georgia
$6.01K – – –
QCG
187
Quadrant Capital Group
Ohio
$5.27K – – –
MPWT
188
MassMutual Private Wealth & Trust
Connecticut
$4.57K – – –
SAM
189
Smartleaf Asset Management
Massachusetts
$4.31K +$181 +7 +4%
SG
190
Sankala Group
Colorado
$3.71K – – –
SS
191
SBI Securities
Japan
$3.5K +$725 +28 +25%
PWMG
192
Private Wealth Management Group
New Jersey
$3.18K – – –
AssetMark Inc
193
AssetMark Inc
California
$2.91K – – –
HNB
194
Huntington National Bank
Ohio
$2.88K – – –
RIL
195
Rothschild Investment LLC
Illinois
$2.71K +$595 +23 +27%
PA
196
Parallel Advisors
California
$2.68K – – –
HRCM
197
Hood River Capital Management
Florida
$2.48K – – –
LFG
198
Larson Financial Group
Missouri
$2.41K – – –
JFGIW
199
Johnson Financial Group Inc (Wisconsin)
Wisconsin
$1.86K – – –
PFBT
200
Parkside Financial Bank & Trust
Missouri
$1.56K – – –
6 7
8
9 10

IMVT Hedge Fund Activity: Q1 2026 in Review

215 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q1 2026, worth a combined $2.75B — down 0.52% from $2.76B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new IMVT positions and 24 closed out — a net gain of 22 holders — while 93 added to existing stakes and 40 trimmed.

The largest buyer was TCG Crossover Management, adding an estimated $72.4M. The largest seller was Armistice Capital, cutting an estimated $56.5M.

  • 215 institutional investors held Immunovant (IMVT) as of Q1 2026, up from 196 in Q4 2025.
  • Funds reported $2.75B of Immunovant stock for Q1 2026, down 0.52% quarter-over-quarter.
  • 46 funds opened new Immunovant positions in Q1 2026 and 24 closed out, a net change of +22 holders.
  • The largest Immunovant buyer in Q1 2026 was TCG Crossover Management, an estimated $72.4M added.
  • The largest Immunovant seller in Q1 2026 was Armistice Capital, an estimated $56.5M sold.

Based on aggregated 13F filings for Q1 2026.